T-cell recognition of cancer epitopes lies at the heart of effective cancer immunotherapy. This symposium will bring together leading experts to discuss the latest advances in cancer T-cell recognition, spanning fundamental mechanisms of antigen presentation and T-cell receptor (TCR) recognition to cutting-edge clinical applications, including TCR-engineered T-cell therapies, cancer vaccine development, and allo-recognition of cancer cells.

Each session will feature internationally recognized keynote speakers alongside selected short talks selected from submitted abstracts, providing a dynamic forum for scientific exchange. Join us in Lausanne, a thriving hub for cancer immunotherapy research at the heart of Europe.

Early bird registration (80CHF) and abstract submission deadline: Jan 15, 2027.

Final registration (100CHF) deadline: Feb 15, 2027.

Fellowships: We are happy to be able to offer fellowships to support 3 researchers from abroad to come and present their research in our symposium. Fellowships are opened for PhDs, Post-docs and early PIs. Following the fellowships sponsor’s guidelines, these are only opened to people outside from Switzerland. The fellowship would cover up to 800 CHF, for the costs of travel and accommodation. To apply for these fellowships, please register to the conference before January 15, 2027, submitting an abstract for a talk. At the same time, send an e-mail indicating your interest for the fellowship, including a short curriculum of maximum 3 pages to julien.racle .at. unil.ch.

For specific enquiries about the symposium, contact us at admin.do .at. unil.ch.